Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 10/20 | 0.77 |
| ▸ | CDK1 | P06493 | 3/20 | 0.77 |
| ▸ | GSK3A | P49840 | 3/20 | 0.77 |
| ▸ | CCNB2 | O95067 | 2/20 | 0.77 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.77 |
| ▸ | CCNB3 | Q8WWL7 | 2/20 | 0.77 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.77 |
| ▸ | CDK2 | P24941 | 1/20 | 0.77 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.77 |
| ▸ | TAOK1 | Q7L7X3 | 1/20 | 0.77 |
| ▸ | SLK | Q9H2G2 | 1/20 | 0.77 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.77 |
| ▸ | CSNK1G1 | Q9HCP0 | 1/20 | 0.77 |
| ▸ | IDH1 | O75874 | 2/20 | 0.40 |
| ▸ | TMPRSS4 | Q9NRS4 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 2/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | ROS1 | P08922 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Laduviglusib SCHEMBL29838591 | 1.00 | GSK3B (0.77) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| Laduviglusib SCHEMBL29381114 | 1.00 | GSK3B (0.77) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| Laduviglusib SCHEMBL17165152 | 0.99 | GSK3B (0.76) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| SCHEMBL12552315 | 0.93 | GSK3B (0.67) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| SCHEMBL5094723 | 0.92 | GSK3B (0.66) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| SCHEMBL4398952 | 0.92 | GSK3B (0.65) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| SCHEMBL4404427 | 0.91 | GSK3B (0.64) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| SCHEMBL20095066 | 0.90 | GSK3B (0.72) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| SCHEMBL26489229 | 0.90 | GSK3B (0.62) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| SCHEMBL7148131 | 0.89 | GSK3B (0.71) | GSK3BCDK1GSK3ACCNB2CCNB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 686 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240352422-A1 | DIRECT REPROGRAMMING OF CELLS INTO CARDIAC PURKINJE-LIKE CELLS USING A UNIVERSAL SMALLMOLECULE COCKTAIL | UNIVERSITY OF HOUSTON SYSTEM (US) | 2024-10-24 | — | — | US | claimed |
| WO-2024136442-A1 | METHOD FOR PREPARING PANCREATIC ISLET ORGANOID USING STATIC SUSPENSION CULTURE METHOD | 주식회사 강스템바이오텍 | 2024-06-27 | — | — | WO | claimed |
| EP-3384007-B1 | IMPROVED METHODS FOR REPROGRAMING NON-PLURIPOTENT CELLS INTO PLURIPOTENT STEM CELLS | BEIHAO STEM CELL AND REGENERATIVE MEDICINE RES INSTITUTE CO LTD (CN) | 2024-03-27 | — | — | EP | claimed |
| WO-2023167986-A1 | METHODS AND COMPOSITIONS FOR TREATING HEARING LOSS | Lineage Cell Therapeutics, Inc. (US) | 2023-09-07 | — | — | WO | claimed |
| US-11655449-B2 | Culture conditions to prolong/enhanced endodermal cell type for cell transplantation | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-05-23 | — | — | US | claimed |
| WO-2023022892-A1 | DIRECT REPROGRAMMING OF CELLS INTO CARDIAC PURKINJE-LIKE CELLS USING A UNIVERSAL SMALLMOLECULE COCKTAIL | UNIVERSITY OF HOUSTON SYSTEM (US) | 2023-02-23 | — | — | WO | claimed |
| US-20220389376-A1 | Methods for Reprogramming Cells | NANTES UNIVERSITE (FR) | 2022-12-08 | — | — | US | claimed |
| CN-110564677-B | Inducer for inducing pluripotent stem cells to differentiate into beating cardiac muscle cells and application thereof | 上海泉生生物科技有限公司 | 2022-09-09 | — | — | CN | claimed |
| WO-2021092657-A1 | METHODS FOR REPROGRAMMING CELLS | MONASH UNIVERSITY (AU) | 2021-05-20 | — | — | WO | claimed |
| US-20210123017-A1 | METHOD FOR PRODUCING DOPAMINERGIC NEURONS | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2021-04-29 | — | — | US | claimed |
| WO-2013129929-A1 | METHODS FOR ACTIVATING RETROVIRUS IN LATENT INFECTED CELLS, AND COMPOUNDS FOR USE THEREIN | ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM (NL) | 2013-09-06 | — | — | WO | claimed |
| US-20130210060-A1 | METHOD OF PRODUCING PANCREATIC HORMONE-PRODUCING CELLS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-08-15 | — | — | US | claimed |
| WO-2013098140-A1 | PERITONEAL DIALYSIS FLUID COMPRISING A GSK-3 INHIBITOR | ZYTOPROTEC GMBH (AT) | 2013-07-04 | — | — | WO | claimed |
| EP-2609918-A1 | Peritoneal dialysis fluid comprising a GSK-3 inhibitor | Zytoprotec GmbH (AT) | 2013-07-03 | — | — | EP | claimed |
| EP-2604685-A1 | METHOD OF PRODUCING PANCREATIC HORMONE-PRODUCING CELLS | Takeda Pharmaceutical Company Limited (JP) | 2013-06-19 | — | — | EP | claimed |
| US-20130022986-A1 | METHOD FOR MANUFACTURING PANCREATIC-HORMONE-PRODUCING CELLS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-01-24 | — | — | US | claimed |
| US-20120190112-A1 | Differentiation of Pluripotent Stem Cells | CENTOCOR ORTHO BIOTECH INC. | 2012-07-26 | — | — | US | claimed |
| EP-2283114-A2 | TREATMENT OF PLURIPOTENT CELLS | Centocor Ortho Biotech Inc. (US) | 2011-02-16 | — | — | EP | claimed |
| US-20090325293-A1 | TREATMENT OF PLURIPOTENT CELLS | JANSSEN BIOTECH, INC. | 2009-12-31 | — | — | US | claimed |
| WO-2009132068-A2 | TREATMENT OF PLURIPOTENT CELLS | CENTOCOR ORTHO BIOTECH INC. (US) | 2009-10-29 | — | — | WO | claimed |